Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Variability: Analysis01:11

Variability: Analysis

636
Measures of variability are statistical metrics that reveal the dispersion pattern within a dataset. They are pivotal in biostatistics, providing insights into the heterogeneity within health and biological data. Variability signifies the degree to which data points diverge from one another, helping researchers understand the potential range of values and associated uncertainty within the data.
The range is a simple measure of variability, indicating the difference between the highest and...
636
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

742
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
742
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

1.1K
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.1K
Errors occurring during blood pressure monitoring01:25

Errors occurring during blood pressure monitoring

1.8K
Blood pressure monitoring is a crucial clinical procedure in diagnosing and managing various cardiovascular conditions. Despite its significance, the accuracy of blood pressure measurements can be compromised by multiple factors, potentially leading to either falsely high or low readings. These inaccuracies are critical as they can significantly impact patient care. So, it is vital to understand these challenges deeply and adopt strategic approaches to minimize errors.
Several factors...
1.8K
Systematic Error: Methodological and Sampling Errors01:15

Systematic Error: Methodological and Sampling Errors

11.4K
In the case of systematic errors, the sources can be identified, and the errors can be subsequently minimized by addressing these sources. According to the source, systematic errors can be divided into sampling, instrumental, methodological, and personal errors.
Sampling errors originate from improper sampling methods or the wrong sample population. These errors can be minimized by refining the sampling strategy. Defective instruments or faulty calibrations are the sources of instrumental...
11.4K
Dosage Regimen: Individualization01:24

Dosage Regimen: Individualization

280
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
280

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Trends in cardiac implantable electronic device infections: 2015 to 2019.

BMC cardiovascular disorders·2026
Same author

Delphi consensus recommendations for preventing and treating cardiac implantable electronic device infections beyond current guidelines.

Scientific reports·2026
Same author

Effects of different blood storage conditions on leukocytes cell population data using the Sysmex XN hematological analyzer.

Biochemia medica·2026
Same author

The urine examination: a modern technological test with a very ancient history.

Advances in laboratory medicine·2026
Same author

Efficacy of topical application of taurolidine 2% in promoting second intention healing of poststernotomy deep incisional wound infection.

General thoracic and cardiovascular surgery cases·2025
Same author

Addressing Complications in Cardiac Implantable Electronic Devices: A Guideline to Prevention of CIED Infection.

Journal of cardiovascular development and disease·2025

Related Experiment Video

Updated: Mar 29, 2026

Assessing the Accuracy of Fitness Smartwatch Data for Cardiovascular and Physical Activity Monitoring: A Validation Study in Digital Health
05:51

Assessing the Accuracy of Fitness Smartwatch Data for Cardiovascular and Physical Activity Monitoring: A Validation Study in Digital Health

Published on: February 21, 2025

1.6K

Pre-analytic variability in cardiovascular biomarker testing.

Roberto Cemin1, Massimo Daves1

  • 11 Department of Cardiology, San Maurizio Regional Hospital of Bolzano, Bolzano, Italy ; 2 Clinical Pathology Laboratory, Hospital of Merano, Merano, Italy.

Journal of Thoracic Disease
|December 2, 2015
PubMed
Summary
This summary is machine-generated.

Pre-analytic variability significantly impacts cardiovascular biomarker testing quality. Understanding factors affecting cardiac troponins and natriuretic peptides is crucial for accurate clinical cardiology results and avoiding errors.

Keywords:
Laboratory variabilitybiomarkercardiology

More Related Videos

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.4K
Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome
06:04

Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome

Published on: September 27, 2024

1.7K

Related Experiment Videos

Last Updated: Mar 29, 2026

Assessing the Accuracy of Fitness Smartwatch Data for Cardiovascular and Physical Activity Monitoring: A Validation Study in Digital Health
05:51

Assessing the Accuracy of Fitness Smartwatch Data for Cardiovascular and Physical Activity Monitoring: A Validation Study in Digital Health

Published on: February 21, 2025

1.6K
Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.4K
Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome
06:04

Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome

Published on: September 27, 2024

1.7K

Area of Science:

  • Laboratory Medicine
  • Clinical Cardiology
  • Biomarker Analysis

Background:

  • Laboratory medicine plays an increasingly vital role in clinical cardiology.
  • Numerous cardiovascular biomarkers have been introduced, enhancing diagnostic capabilities.
  • Pre-analytic variability is a major, often underestimated, source of laboratory errors.

Purpose of the Study:

  • To review the determinants of pre-analytic variability in cardiovascular biomarker testing.
  • To highlight the significance of pre-analytic factors for common biomarkers.
  • To improve the quality of laboratory results in cardiology.

Main Methods:

  • Literature review focusing on pre-analytic variability.
  • Analysis of factors affecting cardiovascular biomarker testing.
  • Emphasis on cardiac troponins and natriuretic peptides.

Main Results:

  • Pre-analytic variability is a substantial source of bias in laboratory testing.
  • Specific determinants of variability for cardiac troponins and natriuretic peptides are identified.
  • Awareness of these factors is essential for physicians.

Conclusions:

  • Addressing pre-analytic variability is critical for reliable cardiovascular biomarker results.
  • Understanding pre-analytic factors enhances the accuracy of clinical cardiology.
  • Minimizing laboratory errors requires attention to pre-analytic sample handling.